Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase versus standard treatment for acute ischemic hemispheric stroke in patients older than 80 years
2007-006177-88Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tissue-plasminogen activator in ischemic stroke and atherothrombotic stroke (2 arms), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Favorable functional outcome at day 90. Started Feb 2008; status: active.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic strokeatherothrombotic stroke
Beyond the preview
Go deeper on 2007-006177-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006177-88.